Page last updated: 2024-10-19

phytic acid and Atypical Ductal Hyperplasia

phytic acid has been researched along with Atypical Ductal Hyperplasia in 1 studies

Phytic Acid: Complexing agent for removal of traces of heavy metal ions. It acts also as a hypocalcemic agent.
myo-inositol hexakisphosphate : A myo-inositol hexakisphosphate in which each hydroxy group of myo-inositol is monophosphorylated.

Research Excerpts

ExcerptRelevanceReference
" The specific objectives of this investigation were: (1) to develop a ceramic delivery system for the novel purpose of releasing sustained levels of the anti-cancer drug combination inositol hexaphosphate (IP6) + inositol (I) in a tissue culture setting; (2) to assess the proliferation rate and viability of HTB 122 Intraductile Breast Cancer (IBC) cells exposed to sustained levels of IP6 + I compared to conventional means of drug delivery (dissolved in media); (3) to evaluate the morphological changes associated with this treatment process."3.70Development of sustained delivery system as a novel technique for tissue culture. ( Benghuzzi, H; Higdon, KK; Hughes, JL; Puckett, A; Scott, A; Tucci, M, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Higdon, KK1
Scott, A1
Benghuzzi, H1
Tucci, M1
Puckett, A1
Hughes, JL1

Other Studies

1 other study available for phytic acid and Atypical Ductal Hyperplasia

ArticleYear
Development of sustained delivery system as a novel technique for tissue culture.
    Biomedical sciences instrumentation, 2000, Volume: 36

    Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Culture Techniques

2000